Clinical and Experimental Reproductive Medicine

Search: Clin Exp Reprod Med Search

CLOSE

Original Article

September 1, 2022

Effect of endometrial cell-conditioned medium and platelet-rich plasma on the developmental competence of mouse preantral follicles: An in vitro study

Neda Taghizabet, Soghra Bahmanpour, Nehleh Zarei-fard, et al.

Clin Exp Reprod Med. 2022;49(3):175-184.

Objective: The aim of this study was to evaluate the impacts of platelet-rich plasma (PRP) and conditioned medium (CM) derived from endometrial stromal cells on mouse preantral follicle culture in...

Original Article

August 31, 2022

Sperm DNA fragmentation negatively influences the cumulative live birth rate in the intracytoplasmic sperm injection cycles of couples with unexplained infertility

Deepthi Repalle, K.V. Saritha, Shilpa Bhandari

Clin Exp Reprod Med. 2022;49(3):185-195.

Objective: This study aimed to determine the effect of sperm DNA fragmentation (SDF) on the cumulative live birth rate (CLBR) in intracytoplasmic sperm injection (ICSI) cycles in couples with unexplained...

Original Article

August 31, 2022

Sperm DNA fragmentation in consecutive ejaculates from patients with cancer for sperm cryopreservation

Seul Ki Kim, Haerin Paik, Jung Ryeol Lee, et al.

Clin Exp Reprod Med. 2022;49(3):196-201.

Objective: This prospective consecutive study investigated the variation in sperm DNA fragmentation (SDF) in multiple semen samples from patients with cancer. Methods: Eighty-one patients with various cancers underwent multiple semen collections...

Original Article

August 31, 2022

Correlation of oocyte number with serum anti-Müllerian hormone levels measured by either Access or Elecsys in fresh in vitro fertilization cycles

Hye Gyeong Jeong, Seul Ki Kim, Jung Ryeol Lee, et al.

Clin Exp Reprod Med. 2022;49(3):202-209.

Objective: The aim of this study was to assess the correlation of oocyte number with serum anti-Müllerian hormone (AMH) levels measured by two automated methods (Access or Elecsys) in fresh...

Original Article

August 31, 2022

Intraovarian platelet-rich plasma administration could improve blastocyst euploidy rates in women undergoing in vitro fertilization

Zaher Merhi, Serin Seckin, Marco Mouanness

Clin Exp Reprod Med. 2022;49(3):210-214.

Objective: Platelet-rich plasma (PRP) therapy has received a considerable attention as an adjunct to fertility treatments, especially in women with very low ovarian reserve and premature ovarian insufficiency. Although recent...

Current Issue: Volume 49(3); Sep 2022

Editorial Office: Department of Obstetrics and Gynecology CHA Bundang Medical Center, CHA University
59 Yatap-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea
Tel: +82-31-727-8701 CP: +82-10-9072-3154 E-mail: hwas0605@cha.ac.kr

Copyright © 2022 by Korean Society for Reproductive Medicine.

prev

next

prev

next